Concurrent Atezolizumab Plus Bevacizumab and High-Dose External Beam Radiotherapy for Highly Advanced Hepatocellular Carcinoma.

Chung-Wei SuWei TengEric Yi-Liang ShenBing-Shen HuangPo-Ting LinMing-Mo HouTsung-Han WuDin-Li TsanChia-Hsun HsiehChing-Ting WangPei-Mei ChaiYung-Chang LinShi-Ming LinChen-Chun Lin

Published in: The oncologist (2024)

The concurrent high-dose external beam radiotherapy appears to safely enhance the effectiveness of atezolizumab plus bevacizumab for highly advanced patients with HCC. Further studies are warranted to confirm these findings.

Keyphrases

high dose
locally advanced
rectal cancer
stem cell transplantation
low dose
early stage
radiation therapy
squamous cell carcinoma
metastatic colorectal cancer
randomized controlled trial
radiation induced
systematic review
monte carlo
electron microscopy
case control